[HTML][HTML] Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data …
Stem Cell Trialists' Collaborative Group - Journal of clinical …, 2005 - ncbi.nlm.nih.gov
Stem Cell Trialists' Collaborative Group
Journal of clinical oncology: official journal of the American Society …, 2005•ncbi.nlm.nih.govAllogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the
Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine
Randomized Trials - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List HHS Author Manuscripts
PMC1475795 Other Formats PubReader PDF (593K) Actions Cite Collections Share Permalink …
Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine
Randomized Trials - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List HHS Author Manuscripts
PMC1475795 Other Formats PubReader PDF (593K) Actions Cite Collections Share Permalink …
Abstract
Purpose
Considerable uncertainty exists regarding relative effects of allogeneic peripheral blood stem cells transplantation (PBSCT) versus bone marrow transplantation (BMT) on outcomes of patients with hematologic malignancies.
ncbi.nlm.nih.gov